Skip to main navigation Skip to search Skip to main content

Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells

  • Paolo Mellini
  • , Biagina Marrocco
  • , Diana Borovika
  • , Lucia Polletta
  • , Ilaria Carnevale
  • , Serena Saladini
  • , Giulia Stazi
  • , Clemens Zwergel
  • , Peteris Trapencieris
  • , Elisabetta Ferretti
  • , Marco Tafani
  • , Sergio Valente
  • , Antonello Mai

Research output: Contribution to journalArticlepeer-review

Abstract

Novel pyrazole-based EZH2 inhibitors have been prepared through a molecular pruning approach from known inhibitors bearing a bicyclic moiety as a central scaffold. The hit compound 1o (N-((4,6-dimethyl-2-oxo-1,2-dihy-dropyridin-3-yl)methyl)-5-methyl-1-phenyl-1H-pyrazole-4-carboxamide) showed low micromolar EZH2/PRC2 inhibition and high selectivity towards a panel of other methyltransferases. Moreover, 1o displayed cell growth arrest in breast MDA-MB231, leukaemia K562, and neuroblastoma SK-N-BE cancer cells joined to reduction of H3K27me3 levels and induction of apoptosis and autophagy.

Original languageEnglish
Article number20170150
JournalPhilosophical Transactions of the Royal Society B: Biological Sciences
Volume373
Issue number1748
DOIs
StatePublished - Jun 5 2018
Externally publishedYes

Keywords

  • Apoptosis
  • Autophagy
  • Enhancer of zeste homologue 2 inhibitors
  • Epigenetics

Fingerprint

Dive into the research topics of 'Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells'. Together they form a unique fingerprint.

Cite this